Dyne Therapeutics (DYN) Institutional Ownership $14.57 -0.21 (-1.42%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$15.08 +0.50 (+3.47%) As of 06/11/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Dyne Therapeutics (NASDAQ:DYN)CurrentInstitutional OwnershipPercentage96.68%Number ofInstitutional Buyers(last 12 months)139TotalInstitutional Inflows(last 12 months)$729.02MNumber ofInstitutional Sellers(last 12 months)68TotalInstitutional Outflows(last 12 months)$336.52M Get DYN Insider Trade Alerts Want to know when executives and insiders are buying or selling Dyne Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DYN Institutional Buying and Selling by Quarter Dyne Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2025 Rhumbline Advisers133,627$1.40M0.0%+4.2%0.118% 5/19/2025 Jane Street Group LLC117,006$1.22M0.0%-26.5%0.103% 5/19/2025 Optimize Financial Inc14,761$154K0.1%N/A0.013% 5/16/2025 Exome Asset Management LLC258,391$2.70M2.3%N/A0.227% 5/16/2025 Caxton Associates LLP14,972$157K0.0%N/A0.013% 5/16/2025 Voleon Capital Management LP 59,673$624K0.0%N/A0.052% 5/16/2025 Goldman Sachs Group Inc.994,886$10.41M0.0%+58.2%0.875% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.56,466$597K0.0%+5.4%0.050% 5/16/2025 AQR Capital Management LLC23,560$246K0.0%N/A0.021% 5/16/2025 ADAR1 Capital Management LLC30,099$315K0.1%N/A0.026% Get the Latest News and Ratings for DYN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dyne Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/15/2025 Vestal Point Capital LP1,800,000$18.83M1.3%N/A1.584% 5/15/2025 RA Capital Management L.P.9,714,392$101.61M1.7%+52.2%8.549% 5/15/2025 Frazier Life Sciences Management L.P.1,443,341$15.10M0.7%N/A1.270% 5/15/2025 Palo Alto Investors LP333,391$3.49M0.7%N/A0.293% 5/15/2025 PDT Partners LLC224,176$2.35M0.2%N/A0.197% 5/15/2025 Braidwell LP3,621,344$37.88M1.3%+431.6%3.187% 5/15/2025 Nantahala Capital Management LLC345,062$3.61M0.1%N/A0.304% 5/15/2025 Cubist Systematic Strategies LLC115,534$1.21M0.0%-3.0%0.102% 5/15/2025 Graham Capital Management L.P.62,269$651K0.0%N/A0.055% 5/15/2025 Armistice Capital LLC2,768,000$28.95M0.4%+187.0%2.436% 5/15/2025 Quarry LP4,500$47K0.0%N/A0.004% 5/15/2025 Siren L.L.C.2,717,987$28.43M1.6%+101.7%2.391% 5/15/2025 Trexquant Investment LP334,443$3.50M0.0%+166.7%0.294% 5/14/2025 Rafferty Asset Management LLC147,353$1.54M0.0%-12.0%0.130% 5/14/2025 Comerica Bank41,176$431K0.0%+16.3%0.036% 5/14/2025 Walleye Capital LLC154,634$1.62M0.0%N/A0.136% 5/14/2025 Atlas Venture Life Science Advisors LLC9,130,465$95.51M18.3%+13.9%8.035% 5/14/2025 AlphaQuest LLC16,332$171K0.0%N/A0.014% 5/14/2025 Candriam S.C.A.463,368$4.85M0.0%+15.4%0.408% 5/14/2025 T. Rowe Price Investment Management Inc.1,167,975$12.22M0.0%N/A1.028% 5/14/2025 Hsbc Holdings PLC28,396$286K0.0%+112.6%0.025% 5/14/2025 Wellington Management Group LLP36,322$380K0.0%-5.8%0.032% 5/13/2025 Algert Global LLC476,007$4.98M0.1%+488.2%0.419% 5/13/2025 Aberdeen Group plc314,586$3.29M0.0%+1,119.2%0.277% 5/13/2025 Fox Run Management L.L.C.17,088$179K0.0%N/A0.015% 5/13/2025 E Fund Management Co. Ltd.13,771$144K0.0%+16.2%0.012% 5/13/2025 Caitong International Asset Management Co. Ltd3,092$32K0.0%+378.6%0.003% 5/13/2025 Russell Investments Group Ltd.67,877$710K0.0%-41.9%0.060% 5/12/2025 Nuveen LLC223,215$2.34M0.0%N/A0.196% 5/12/2025 Invesco Ltd.66,293$693K0.0%+64.4%0.058% New Rule Hits in July — The Smart Money Already Moved (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how5/12/2025 Swiss National Bank118,300$1.24M0.0%+8.9%0.104% 5/9/2025 Deutsche Bank AG317,664$3.32M0.0%+347.7%0.280% 5/9/2025 Charles Schwab Investment Management Inc.654,131$6.84M0.0%-2.0%0.576% 5/9/2025 Vanguard Group Inc.7,406,344$77.47M0.0%+10.5%6.518% 5/9/2025 Privium Fund Management B.V.27,566$288K0.1%+35.4%0.024% 5/8/2025 Aegis Wealth Management LLC33,228$348K0.2%N/A0.029% 5/8/2025 XTX Topco Ltd31,574$330K0.0%N/A0.028% 5/8/2025 GSA Capital Partners LLP98,597$1.03M0.1%N/A0.087% 5/7/2025 Zurcher Kantonalbank Zurich Cantonalbank 19,247$201K0.0%+22.2%0.017% 5/7/2025 TD Asset Management Inc21,656$227K0.0%-69.9%0.019% 5/6/2025 Y Intercept Hong Kong Ltd80,665$844K0.1%+725.8%0.071% 5/2/2025 Victory Capital Management Inc.59,411$621K0.0%-3.2%0.052% 5/1/2025 Arizona State Retirement System17,501$183K0.0%+9.2%0.015% 4/30/2025 China Universal Asset Management Co. Ltd.22,690$237K0.0%+5.2%0.020% 4/29/2025 Bank of New York Mellon Corp232,626$2.43M0.0%-0.9%0.205% 4/15/2025 SG Americas Securities LLC430,051$4.50M0.0%+2,159.1%0.380% 4/8/2025 Rhumbline Advisers133,627$1.40M0.0%+4.2%0.118% 4/7/2025 GAMMA Investing LLC2,625$251K0.0%+837.5%0.002% 3/24/2025 Wellington Management Group LLP38,550$908K0.0%-7.5%0.034% 2/19/2025 GF Fund Management CO. LTD.2,137$50K0.0%N/A0.002% 2/18/2025 Neo Ivy Capital Management8,715$205K0.0%N/A0.009% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC143,363$3.38M0.0%+6.7%0.141% 2/17/2025 Voloridge Investment Management LLC119,015$2.80M0.0%N/A0.117% 2/17/2025 Woodline Partners LP573,957$13.52M0.1%-41.3%0.564% 2/17/2025 Squarepoint Ops LLC51,616$1.22M0.0%-38.0%0.051% 2/17/2025 Two Sigma Advisers LP76,100$1.79M0.0%+25.4%0.075% 2/17/2025 Sphera Funds Management LTD.236,262$5.57M1.0%+318.1%0.232% 2/17/2025 RTW Investments LP5,218,641$122.95M1.9%-23.5%5.128% 2/17/2025 Rafferty Asset Management LLC167,482$3.95M0.0%+1.5%0.165% 2/17/2025 Point72 Asset Management L.P.924,681$21.79M0.0%+802.3%0.909% 2/17/2025 ProShare Advisors LLC28,044$661K0.0%+32.4%0.028% 2/17/2025 Man Group plc746,463$17.59M0.0%+3.9%0.733% 2/17/2025Nuveen Asset Management LLC266,404$6.28M0.0%-3.6%0.262% 2/17/2025 Orbimed Advisors LLC1,227,080$28.91M0.6%+73.2%1.206% 2/17/2025 Octagon Capital Advisors LP668,000$15.74M2.6%+154.3%0.656% 2/17/2025 Millennium Management LLC37,536$884K0.0%+526.5%0.037% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.53,580$1.26M0.0%+5.7%0.053% 2/17/2025 Integral Health Asset Management LLC150,000$3.53M0.3%N/A0.147% 2/17/2025 Janus Henderson Group PLC7,379,309$173.81M0.1%+8.3%7.251% 2/17/2025Jefferies Financial Group Inc.1,800,000$42.41M0.2%N/A1.769% 2/17/2025 Ensign Peak Advisors Inc315,602$7.44M0.0%+0.9%0.310% 2/17/2025 Farallon Capital Management LLC229,121$5.40M0.0%-46.5%0.225% 2/17/2025 Fcpm Iii Services B.V.5,462,846$128.71M21.8%-8.3%5.368% 2/17/2025 FORA Capital LLC9,235$218K0.0%-49.2%0.009% 2/17/2025 Frontier Capital Management Co. LLC298,052$7.02M0.1%N/A0.293% 2/17/2025 Deutsche Bank AG70,961$1.67M0.0%+51.4%0.070% 2/17/2025 D. E. Shaw & Co. Inc.133,772$3.15M0.0%+83.1%0.131% 2/17/2025 Deep Track Capital LP2,000,000$47.12M1.8%-39.1%1.965% 2/17/2025 Crestline Management LP184,818$4.35M0.1%+57.0%0.182% 2/17/2025 Cubist Systematic Strategies LLC119,065$2.81M0.0%N/A0.117% Trump set to Boost Social Security Checks by 400%? (Ad)If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...Click here to see the details because the stakes couldn't be any higher.2/17/2025 Braidwell LP681,182$16.05M0.5%N/A0.669% 2/17/2025 Brevan Howard Capital Management LP28,781$678K0.0%N/A0.028% 2/17/2025 Balyasny Asset Management L.P.169,306$3.99M0.0%-30.9%0.166% 2/17/2025 Bank of America Corp DE122,641$2.89M0.0%-58.0%0.121% 2/17/2025 BNP Paribas Financial Markets66,998$1.58M0.0%N/A0.066% 2/17/2025 Ameriprise Financial Inc.219,635$5.18M0.0%+3.2%0.216% 2/17/2025 Algert Global LLC80,923$1.91M0.0%-14.8%0.080% 2/17/2025 ArrowMark Colorado Holdings LLC932,231$21.96M0.3%+3.6%0.916% 2/14/2025 Comerica Bank35,409$834K0.0%+20,133.7%0.035% 2/14/2025 First Light Asset Management LLC420,431$9.91M0.9%-66.6%0.413% (Data available from 1/1/2016 forward) DYN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DYN shares? During the previous two years, 201 institutional investors and hedge funds held shares of Dyne Therapeutics. The most heavily invested institutionals were FMR LLC ($188.41M), Janus Henderson Group PLC ($173.81M), State Street Corp ($130.82M), Fcpm Iii Services B.V. ($128.71M), RTW Investments LP ($122.95M), RA Capital Management L.P. ($101.61M), and Atlas Venture Life Science Advisors LLC ($95.51M).Learn more on DYN's institutional investors. What percentage of Dyne Therapeutics stock is owned by institutional investors? 96.68% of Dyne Therapeutics stock is owned by institutional investors. Learn more on DYN's institutional investor holdings. Which institutional investors have been buying Dyne Therapeutics stock? Of the 172 institutional investors that purchased Dyne Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($8.62M), Fcpm Iii Services B.V. ($6.13M), Janus Henderson Group PLC ($5.42M), Braidwell LP ($4.07M), FMR LLC ($3.71M), Frazier Life Sciences Management L.P. ($2.63M), and VR Adviser LLC ($2.17M). How much institutional buying is happening at Dyne Therapeutics? Institutional investors have bought a total of 64,095,465 shares in the last 24 months. This purchase volume represents approximately $1.26B in transactions. Which Dyne Therapeutics major shareholders have been selling company stock? Of the 80 institutional investors that sold Dyne Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wasatch Advisors LP ($1.95M), Atlas Venture Life Science Advisors LLC ($1.87M), Vida Ventures Advisors LLC ($1.81M), RTW Investments LP ($1.60M), Logos Global Management LP ($1.47M), Deep Track Capital LP ($1.28M), and FMR LLC ($1.08M). How much institutional selling is happening at Dyne Therapeutics? Institutional investors have sold a total of 20,190,604 shares in the last 24 months. This volume of shares sold represents approximately $513.21M in transactions. Related Companies Grifols Institutional Ownership Telix Pharmaceuticals Limited American Depositary Shares Institutional Ownership TG Therapeutics Institutional Ownership Nuvalent Institutional Ownership Legend Biotech Institutional Ownership Lantheus Institutional Ownership Axsome Therapeutics Institutional Ownership ADMA Biologics Institutional Ownership Vaxcyte Institutional Ownership Merus Institutional Ownership This page (NASDAQ:DYN) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyne Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dyne Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DYN Stock Free DYN Stock Alerts